Sheikh and team publish guide for conducting CAR T-cell trials for patients with SLE
January 13, 2026
Chimeric antigen receptor (CAR) T-cell therapies, best known for its cancer-treating abilities, are being explored as an option for managing autoimmune rheumatic diseases. A team of investigators, including Saira Sheikh, MD, published a guide in ACR Open Rheumatology, providing a detailed exploration of the framework required for rheumatologists to initiate...